Skip to content
To the full analysis

PolyPeptide Group stock: dividend

PPGN.SW
$48.49Closing price of 12 Nov 2026MEQIRI Score 42 out of 100

PolyPeptide Group does not currently pay a dividend; its last payment went ex on 28 Apr 2022. From fiscal 2023 to 2025, PolyPeptide Group bought back its own shares for $539.82K.

Whether PolyPeptide Group AG pays a dividend and what the company does with its cash instead: free cash flow, buybacks of its own shares and the share count over recent years.

Daily figure as of 13 Nov 2026

Dividend dates and payments

Anyone holding the stock on the day before the ex-dividend date receives the dividend. Amounts are per share, before tax.

Last ex-dividend date
28 Apr 2022
$0.3601, paid 2 May 2022
Next ex-dividend date
not announced yet
Frequency
no data
All 1 payments of the last five years
Ex-dividend datePayment dateDividend per share
28 Apr 20222 May 2022$0.3601

Free cash flow and buybacks

Fiscal yearFree cash flowShare buybacksShares outstanding
2025−$33.73M$539.82K32.99M
2024$2.69M$032.93M
2023−$22.44M$032.94M
2022−$77.17M$15.44M32.99M
2021−$18.4M$6.05M32.10M
Buyback calculator for PolyPeptide Group

Data status and sources

Score
Daily value of 13 Nov 2026, recalculated nightly
Price
Closing price of 12 Nov 2026
Latest annual report
Fiscal year 2025, period end 31 Dec 2025
Currency
Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = CHF 0.8331, $1 = €0.9024)
Source
Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.

Mandatory disclosures for this rating

  • ; time horizon around 12 months
  • Rated Weak, published since 7 Nov 2026 (in the score history since 30 Apr 2023)
  • Valuation signal Fairly valued since 7 Nov 2026
  • End-of-day prices, metrics cached for up to 24 hours
  • Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
  • Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
  • Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.

MEQIRI counts visits without cookies. With your consent we remember for 90 days where you came from, also in your account, count page changes and time on page, recognise your next visit and load the Meta Pixel, which measures our advertising. You can withdraw your consent at any time under Cookie settings. Privacy